Results 1 to 10 of about 281,298 (260)
Synchronous primary breast invasive carcinoma and breast metastasis from high-grade serous ovarian carcinoma: a case report and literature review. [PDF]
Front OncolBackgroundBreast metastasis from high-grade serous ovarian carcinoma is rare, and its coexistence with a synchronous primary breast carcinoma is exceptionally uncommon.
Miao J +9 more
europepmc +2 more sources
A rare case of pure-type embryonal carcinoma in a 75-year-old woman mimicking epithelial ovarian carcinoma [PDF]
Kosin Medical Journal, 2022 Embryonal carcinoma, a very rare ovarian germ cell tumor, involves pure and mixed phenotypes. Pure-type embryonal carcinoma has never been reported in postmenopausal women. The current case was, thus, misdiagnosed as an epithelial ovarian carcinoma based
Hyun Been Jo +7 more
doaj +1 more source
Expression Level of Cyclin-D1 between Endometriomas and Ovarian Carcinomes
Mutiara Medika, 2021 Endometrioma on the ovaries is a benign gynecological disorder that is often found in women of reproductive age. The approach was made to the malignant transformation through the study of cyclin-D1 expression.
Alfun Dhiya An +1 more
doaj +1 more source
Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
Journal of Ovarian Research, 2023 Background 2020 World Health Organization Classification of Female Genital Tumors removed ovarian seromucinous carcinoma as a distinct entity and recategorized it as ovarian endometrioid carcinoma with mucinous differentiation according to its ...
Yi Hu +6 more
doaj +1 more source
Frontiers in Oncology, 2022 BackgroundOwing to its extremely low incidence and the paucity of relevant reports, there is currently no recognized first-line treatment strategy for ovarian large-cell neuroendocrine carcinoma, and there are no statistics related to prognosis derived ...
Li Pang, Zhiqiang Guo
doaj +1 more source
Importance of Potential New Biomarkers in Patient with Serouse Ovarian Cancer
Diagnostics, 2021 Ovarian cancer remains the gynecological cancer with the highest mortality rate. In our study, we compare a number of proteins from different effector pathways to assess their usefulness in the diagnosis of ovarian cancer.
Aneta Cymbaluk-Płoska +5 more
doaj +1 more source
Clinical Medicine Insights: Case Reports, 2023 Background: Clear cell ovarian carcinoma is rare and accounts for 1%-12% of ovarian epithelial carcinomas, depending on ethnicity. The prevalence of clear cell ovarian carcinoma in Asian, White, and Black women is 11.1%%, 4.8%, and 3.1%, respectively ...
Yoan Alexandria Angelina +1 more
doaj +1 more source
Diagnostics, 2021 The term “ovarian carcinoma” encompasses at least five different malignant neoplasms: high-grade serous carcinoma, low-grade serous carcinoma, endometrioid carcinoma, mucinous carcinoma, and clear cell carcinoma.
Giacomo Santandrea +7 more
doaj +1 more source
Ovarian Clear Cell Carcinoma which Detected in Ascitic Fluid Smear
Andalas Obstetrics and Gynecology Journal, 2021 Objective: To report the case of ovarian clear cell carcinoma with involvement of both ovaries and metastatic to ascitic fluid and the label mass in the bladder Method: Case Report Case: A 51 years old female presented with enlarging abdominal with ...
Muthia Kamelia +2 more
doaj +1 more source
Progesterone reduces cell survival in primary cultures of endometrioid ovarian cancer
Journal of Ovarian Research, 2019 Background Ovarian cancer is the most lethal of all gynecologic malignancies. The relationship between sexual steroids receptors and ovarian cancer progression has been largely evaluated. The presence of progesterone receptors has been associated with an
Enrique Pedernera +4 more
doaj +1 more source